A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...
BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...
Hope is crucial for those of us with chronic lymphocytic leukemia, or any cancer, helping us navigate the disease's ...
From the reveal of NBA star Dwayne Wade’s cancer surgery to a Bachelorette star on her husband’s cancer diagnosis, here is ...
Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...
After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...
The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...
Dr. Anna Arthur discusses the NOURISH trial, which aims to address food insecurity and malnutrition in patients with blood ...
For a person who loved to hike; do aerobic exercises with Billy Blanks, Gilead, Denise Austin and Jane Fonda every day (I ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.
Dr. David A. Braun delved into the molecular factors which drive exceptional responses to immunotherapy in metastatic clear cell renal cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback